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Executive Summary
This article introduces a new approach for evaluating the quality of health care
providers, including an integrated solution to several problems that limit the
usefulness of available methods. Our approach combines information from all
the quality indicators available for a provider (e.g., from other years, other pa-
tients, or other indicators for the same patients) to estimate more accurately the
provider's previous or expected quality. The approach also provides an empiri-
cal basis for comparing and combining alternative quality indicators, thereby
enabling policy makers to choose among potential indicators, explore the po-
tential bias in alternative measures, and increase the value of quality measures
for assessing and improving care. Using hospital care for elderly heart attack
patients as an example, we demonstrate that these methods can be used to cre-
ate reliable, precise predictions about provider quality. Comparing quality of
care across providers may be far more feasible than many now believe.
I.Introduction
Comparing quality of care across providers is becoming increasingly
important, both as a contracting and quality improvement tool for
health plans and payers, and as "report cards" to help consumers and
others compare quality of care. Examples include rankings of the
"best" hospitals published by magazines such as US News & World Re-
port, scorecards issued by state regulators in Pennsylvania and New
York, and hospital quality reports produced by the Health Care Fi-
nancing Administration (HCFA) and the Agency for Healthcare Re-
search and Quality (AHRQ).
Despite enormous interest in developing such quality assessment
tools in health care, these measures have generated much controversy
and skepticism. The problem with many of these rankings is that they
simply are not viewed as particularly informative (Hofer et al. 1999;114 McClellan and Staiger
lezzoni 1997). This perception is especially true for measures based on
important patient outcomes, which tend to be imprecise and particu-
larly susceptible to differences in patient severity and comorbidity be-
cause of the relatively small samples of patients seen by most providers
in a single year. In particular, providers identified as providing high
quality care in one year often appear to provide low quality care in the
subsequent year. For example, table 5.1 shows how hospitals identified
in 1990 as the "best" (top 10 percent) hospitals on one common quality
indicator, thirty-day mortality rate following a heart attack, were
ranked in subsequent years (this data is described in more detail be-
low). Hospitals that were identified as the "best" in 1990 were nearly as
likely to be ranked among the worst (14.7 percent) as among the best
(16.7 percent) by 1994. In fact, average mortality rates among these hos-
pitals were actually higher than average by 1994. This type of evidence
has led many to wonder whether rankings based on such data do more
harm than good (Bindman 1999).
Most of the existing provider report cards have responded to these
perceived problems by moving away from an emphasis on serious out-
comes of important health problems. For example, HEDIS measures
have emphasized screening and relatively common process measures
of care. Other evaluators have focused on larger hospitals or groups of
physicians. Others have argued for expensive collection of detailed
case-mix measures to reduce noise and bias. Still others have advo-
cated collecting large numbers of measures and aggregating them ac-
cording to a priori rules.
These perceived problems with provider report cards have resulted
in considerable debate over the uses of such information. But given
the growing pressures placed on health care providers to provide
efficient high quality care, the trend toward greater accountability
will continuewith increasing pressure to develop and apply mea-
sures to finer levels of analysis (e.g., individual physicians, particular
groups of patients). Thus, the fundamental question is, can we develop
better methods for comparing quality across providers in such
situations?
In a series of recent papers (McClellan and Staiger 1999a, 1999b;
Geppert, McClellan, and Staiger 2000), we have developed methods
that address these concerns and have applied our approach in ongoing
work to implement better quality evaluation and improvement meth-
ods for private health plans, health care purchasing groups, and
Medicare. We refer to our new quality indicators as "filtered" estimates
of provider quality because one of the key advantages of these indica-Comparing the Quality of Health Care Providers 115
Table 5.1
Comparisons of hospital rankings: 1990, 1992, and 1994
Of the hospitals ranked in the best 10% in 1990:
1992
What percentage were still ranked in the best
10% (lowest mortality rates)?
What percentage were ranked in the worst
10% (highest mortality rates)?
Average difference in mortality rate from all
other hospitals (standard error of estimate)
1994
What percent were still ranked in the best
10% (lowest mortality rates)?
What percent were ranked in the worst 10%
(highest mortality rates)?
Average difference in mortality rate from all
other hospitals (standard error of estimate)









Note:Rankings based on conventionalprofiling methods. Outcome measure:
risk-adjusted thirty-day AMI mortality among the elderly.
tors is that they filter out the estimation error that plagues conven-
tional quality indicators and that leads to the type of instability seen in
table 5.1. By integrating these methods with measures of important
processes and outcomes of care, we can develop more precise, compre-
hensive, and informative quality evaluations than have previously
been possible. This article provides an overview of the method and il-
lustrates its application in evaluating the quality of hospital care for el-
derly heart attack patients. Readers interested in the technical details,
along with a more comprehensive empirical evaluation of the perfor-
mance of our approach, are referred to our earlier articles, particularly
McClellan and Staiger (1999a).
Our method combines information from all the quality indicators
available for a provider (e.g., from other years, other patients, or other
indicators for the same patients) to estimate more precisely the pro-
vider's current or future quality level. The basic idea is simple. Any
single quality indicator for a provider will be a very imprecise, that is,
"noisy" measure of that provider's quality. But the array of quality in-
dicators that we observe for a provider is likely to be related across dif-
ferent quality measures and over time. Therefore, the core idea of our116 McClellan and Staiger
method is to use these relationships between multiple measures and
over time to extract a more accurate "signal" in each particular meas-
ure. In addition to improving the precision of the estimated quality in-
dicators, our method provides an empirical basis for comparing
alternative quality indicators and exploring potential biases. This ap-
proach enables one to choose among potential indicators and, in many
cases, limit the number of quality indicators either collected or
reported.
Our particular application of these methods illustrates many of the
challenges facing quality evaluation in health care. On one hand, heart
disease is the leading cause of death in the United States and is clearly a
condition for which the quality of medical care may have a substantial
impact on an individual's health. On the other hand, most hospitals
treat relatively few heart attack patients in any given year, and conven-
tional quality indicators of the most important outcomes, such as sur-
vival, are imprecise because of the influence of many factors besides
hospital quality. We use this example to demonstrate how our filtering
methods can be used to create reliable, precise predictions about pro-
vider quality. In the conclusion, we discuss additional promising appli-
cations of our work to improving health care quality.
II.Uses and Limitations of Conventional Quality Indicators
Uses of Quality Indicators
Comparing quality of care across providers is an increasingly impor-
tant tool as the health care market is becoming more competitive. The
Institute of Medicine (1990) has defined quality as "the degree to which
health services for individuals and populations increase the likelihood
of desired health outcomes and are consistent with current professional
knowledge." But to translate this general definition into concrete
quality indicators, one must ask how the indicators will be used and
consider the features that are required of a quality indicator in that use.
Why do we measure quality7 Ultimately, the goals are to help guide
decision making and improve quality of care. To achieve these goals,
information on provider quality is used primarily in three ways: for
contracting with providers, for guiding consumers in making informed
choices among providers, and for identifying exemplary providers to
serve as models of best practice.
Quality information is used in contracts between purchasers and
providers as a way of providing incentives to the provider to maintainComparing the Quality of Health Care Providers 117
quality of care. Such incentives have become an increasingly important
safeguard because purchasers have moved toward capitation and
other fixed-price contracts that place financial pressure on providers to
reduce the cost of care. This use of quality information is largely back-
ward looking, for example, basing financial rewards on whether the
provider achieved concrete and quantifiable quality standards over the
previous year.
Quality information is also used to guide consumers (and other pur-
chasers such as employers and health plans) in making informed
choices among providers. In today's health care market, providers are
increasingly competing for patients on the basis of price, which in turn
increases the incentives for providers to reduce the amount of care
given to patients. Not surprisingly, lack of accurate quality information
can result in reduced quality in a competitive market (Dranove and
Satterthwaite 1992). Therefore, providing purchasers with accurate
quality information so that they can make informed trade-offs between
cost and quality is a cornerstone of competitive approaches (Enthoven
and Kronick 1989). This use of quality information is largely forward
looking, trying to forecast current or future quality based on available
data from the past.
Finally, quality information is used to identify exemplary providers
who serve as models of best practice (or to identify low-quality provid-
ers for some form of intervention). This approach is a management tool
used to encourage the adoption of best practice as part of many quality
improvement initiatives. This use of quality information also tends to
be forward looking, using data from the past to identify providers for
which the quality of care is currently likely to be particularly good or
bad.
Limitations of Conventional Quality Indicators
A key obstacle to using quality indicators in any of these ways is the
substantial amount of imprecision associated with almost all important
measures of provider quality. Most serious health problems, such as
heart attacks, are relatively infrequent; many hospitals may treat only a
few dozen patients or fewer over an entire year. And most major out-
comes, such as long-term mortality, will be influenced by an enormous
number of factors other than the quality of the provider. Therefore, it is
almost impossible to assess any single outcome measure for a particu-
lar provider with any degree of precision. As a result, these measures
are often poor indicators of past and future performance.118 McClellan and Staiger
This lack of precision in conventional quality indicators limits their
practical value. Contracts that reward providers based on an imprecise
indicator provide weak incentives (because the reward is only weakly
related to actual quality of care) while exposing providers to unneces-
sary financial risk. Inaccuracy can also lead to a lack of trust in the qual-
ity indicators, leading both purchasers and health providers to ignore
the measures in decision making (Bindman 1999; Schneider and Ep-
stein 1998). Finally, inaccuracy in conventional quality indicators will
lead to a mislabeling of many ordinary providers as "exemplary" (as
was suggested in table 5.1), thereby limiting our ability to learn from
the experience of successful providers.
The natural response to this lack of precision is to refocus attention
on measures for which the noise problem is less of an issue: health
plans or medical groups rather than individual physicians, large teach-
ing hospitals rather than all hospitals in a community or preventive
care and common illnesses rather than more serious illness. For exam-
ple, the National Committee for Quality Assurance (NCQA), one of the
leading organizations in the development of quality assessment mea-
sures, has focused on developing measures for which more than 400
cases per sample can reasonably be collected in a specific time period
(e.g., six months or a year). This approach rules out measures for small
providers (e.g., physicians) and for nearly all conditions serious
enough to require hospital care.
This push toward more aggregation moves us in the wrong direction
in terms of how consumers, purchasers, and health plans would like to
use quality measures. Such aggregate measures provide poorly tar-
geted incentives and are at best crude guides for identifying "exem-
plary" providers. By excluding many providers from consideration, we
reduce the relevance of the measures for guiding decisionsespecially
because quality problems areoftengreaterforlower-volume
providers.
Another response to the lack of precision in conventional quality in-
dicators has been to collect and report information on a large number
of indicators in the hope that this will overcome the limitations of any
one indicator. Most provider report cards report information on several
quality indicators, including measures of patient satisfaction, preven-
tive care, process of care, and patient outcomes such as death or impor-
tant complications. For example, the California Healthcare Foundation
medical group report card (QA Tool) has almost 1,100 measures.
The multidimensionality of current quality information raises two
important concerns. First, the cost of collecting and processing this dataComparing the Quality of Health Care Providers 119
is significant (Medicine & Health 1997). Some measures, such as
long-term mortality, require costly follow-up and necessarily involve
long reporting delays. Other measures require detailed chart review,
which can be even more costly. Thus, from a practical perspective, we
would like to target scarce resources on a few core indicators and elimi-
nate redundant or otherwise unnecessary measures, particularly those
that require additional costly data collection or that lead to delay. A sec-
ond problem with the multidimensionality of current quality report
cards is that the complexity makes them difficult to interpret. One ex-
pects that many of the measures are capturing a similar dimension of
quality (e.g., surgical skill or quality of the staff in a particular specialty
such as obstetrics). Thus, a systematic method that reduces many
closely related measures into one, or identifies the one measure that
best summarizes this dimension, would be valuable.
A final response to the perceived lack of reliability of conventional
quality indicators has been to collect more detailed information on pa-
tient condition (severity and comorbidity), often from patient charts, to
control more effectively for differences in patient condition across pro-
viders. The debate has been extensive over the potential bias in con-
ventional quality indicators because of not controlling carefully for
patient condition, but the empirical evidence for the existence of bias is
mixed (Landon et al. 1996; Krakauer et al. 1992; Park et al. 1990). This
debate is critical to the future of quality assessment because the high
cost of gathering detailed information on patient condition can make
quality assessment infeasible in the long term. For example, in a recent
attempt to investigate this issue, HCFA collected chart information on
all Medicare hospital admissions for cardiac conditions in 1994-1995,
but the cost was over $100 per case (Jeffrey Newman, personal commu-
nication, 1998). Obviously, it would be useful to have a systematic
method for determining whether the additional expense of such mea-
sures was necessary.
III. A Brief Overview of the Filtering Method
Past work comparing quality of care in hospitals has generally relied
on a single hospital outcome measure in a given year. For example, to
compare mortality rates at two hospitals, one would simply calculate
the average mortality rate at each hospital, generally adjusting for dif-
ferences across hospitals in patient demographics and comorbidities,
and assess whether the difference in this risk-adjusted mortality rate
between the two hospitals was statistically significant. The limitation120 McClellan and Staiger
of this approach is that the estimates of mortality rates at any given
hospital are generally imprecise because of the typically small samples
of patients treated at a given hospital. For example, in a sample with
100 patients in each hospital, this approach generally cannot detect a
significant difference if one hospital is estimated to have a 16 percent
mortality rate and the other a 24 percent mortality rate. Typically, qual-
ity indicators are based on even smaller samples and the imprecision is
even greater.
As an alternative, one can combine information from all the outcome
measures available for a given hospital (e.g., other years, other pa-
tients, other outcomes for the same patients) to estimate more precisely
a hospital's current quality. This approach is taken by McClellan and
Staiger (1999a). We provide a nontechnical overview of the method
below.
Suppose we observe a vector of conventional quality indicators (M1)
for each hospital (i). Each quality indicator is an estimate of the average
of some variable thought to be related to quality of care, based on a
sample of patients treated at that hospital over a specified period of
time (for example, one year). Thus, M1 might include measures of
risk-adjusted mortality rates, average length of stay, rates of certain
treatments, complication rates, or patient satisfaction levels. Each of
these measures may be available for a range of patient samples, such as
heart attack patients, very low birthweight infants, or those differenti-
ated by insurance coverage. In addition, M1 might include past years of
information on many of these measures. In other words, one can think
of M1 as potentially including all of the conventional quality indicators
that have ever been collected for a given hospital.
Conventional quality indicators are based on a sample of patients
and are therefore imprecise estimates of what we really wish to meas-
ure. In any given year, even a high quality hospital may have poor pa-
tient outcomes because of chance events. This possibility is particularly
likely when a quality indicator is based on only a handful of patients,
so that the outcome of one or two patients will materially influence that
hospital's estimate. Thus, we can think of the observed vector of qual-
ity indicators (Mi) as estimates of the true quality indicators (p) that are
of interest:
= .Lj + (5.1)
whereis the estimation error (which will tend to be larger for hospi-
tals with smaller samples of patients).Comparing the Quality of Health Care Providers 121
Our problem is how to use the entire vector of observed quality indi-
cators for each hospital (Mi) to best predict true quality differences
across hospitals (pa). Conceptually, we can think of our problem as sim-




where f3 is a matrix of regression coefficients that provides the weights
that should optimally be put on each quality indicator to predict most
accurately the true quality differences across hospitals. One wouldex-
pect these weights to vary by hospital because the precision of the ob-
served quality indicators varies by hospital.
We cannot run a simple regression to estimate the weights inequa-
tion (5.2) because the true quality differences across hospitalsare unob-
served. Therefore, conventional provider report cards simplyreport
the observed quality indicators as the best estimates of the true quality
differences. This estimation is equivalent to assuming that each quality
indicator has no error and, by itself, is the best predictor of the
true quality differencesthat is, the weight matrix in equation (5.2)(nj)
has ones along the diagonal and zeros everywhere else.
But there are two problems with this approach. First, because the
quality indicators (Mi) are estimated witherror, we can improve the
mean squared error of the prediction by attenuating the coefficient to-
ward zero. This attenuation should be greater for hospitals in which
the quality indicators are not estimated precisely. This premise is the
basic idea behind Bayesian shrinkage estimators (Morris 1983): the ob-
served variation in quality indicators will tend to overstate the amount
of actual variation across hospitals, so by pulling all the estimates (es-
pecially the more imprecise estimates) back toward themean, we can
improve prediction accuracy. The second problem with theconven-
tional method is that it does not use any of the information available in
other quality indicators. If the true quality differencesacross hospitals
for other outcomes (e.g., other years, other patients)are correlated with
the quality difference we are trying to predict, then using the informa-
tion in estimates of these other quality indicatorscan improve predic-
tion accuracy.
McClellan and Staiger (1999a) develop a simple method for creating
estimates of i, based on equation (5.2), that incorporates both the
shrinkage idea and information from all available quality indicators.122 McClellan and Staiger
The key to the solution is noting that estimating the optimalweights in
equation (5.2) is analogous to estimating regression coefficients.The
standard formula for estimating the regression coefficients in equation
(5.2)is:
= [Var(M)]1 Cov(M,t1) =[Var(i) + Var(e1)]1 Var(ji) (5.3)
Thus, to form the optimal predictions of true quality differences across
hospitals based on equation (5.2) one needs to estimate two matrices:
The variance-covariance matrix of the estimation error of theob-
served quality indicators [Var()11. This matrix represents the preci-
sion in each quality indicator at each hospital. Thismatrix can be
calculated in a straightforward manner, as is currently done when
reporting the standard errors of conventional quality indicators.
The variance-covariance matrix of the true quality differences across
hospitals [VarQ.t)1. This matrix represents the correlation in true
quality differences across measures and over time. To estimate this
we note that Var(i) = Var(M) -Var(e). Thus, we can estimate the to-
tal variance in true quality differences across hospitals by subtract-
ing the variance in the estimation error from the variancein the ob-
served quality indicators.
Finally, we summarize the correlation across measures and over time
with a time-series model (a vector auto-regression), whichallows the
construction of out-of-sample forecasts. This type of time-seriesmodel
places little structure on the correlations and is commonlyused as a
flexible model for forecasting. For details of how this model is esti-
mated and its empirical performance, see McClellan and Staiger
(1999a).
To summarize, our method proceeds in three stages. First, we calcu-
late a vector of conventional quality indicators for each hospitaland for
as many years as data areavailable. Second, we estimate the variance
of the estimation error for the observed quality indicators [Var(s)]and
the variance of the true quality differences across hospitals [Var(iiYI as
discussed above. Finally, we use these variance estimates to form pre-
dictions of true quality differences across hospitals based on equation
(5.2) and using optimal weights derived from equation (5.3). Werefer
to estimates based on equation (5.2) as "filtered"estimates because
these estimates seek to filter out the estimation error in the conven-
tional quality indicators (and because our method is closelyrelated to
the idea of filtering in time series).Comparing the Quality of Health Care Providers 123
IV.Comparing Hospitals Based on Outcomes for Elderly Heart
Attack Patients
In this section, we summarize some of our recent work applying these
methods to compare hospitals based on their quality ofcare for elderly
heart attack patients (McClellan and Staiger 1999a, 1999b;Geppert,
McClellan, and Staiger 2000). We begin by briefly describing thedata.
We then use three illustrative examples to demonstrate thevalue of our
filtering method. First, we show that rankings basedon the filtered
measures are relatively stable over time and can forecast sizable differ-
ences across hospitals two to four years in the future. Second, we show
that the filtered measures can be used tocompare alternative quality
indicators, choose among potential indicators, and evaluate the bias in
measures that do not fully control for differences in patient severity
and comorbidity across hospitals. Finally,we show that the filtered
measures can be used to make meaningful comparisons across hospi-
tals in a large metropolitan region.
Data
We use the same data as in McClellan and Staiger (1999a) for this analy-
sis. Our hospital performance measures include seriousoutcomes
mortality, and cardiac complications requiring rehospitalizationfor
all elderly Medicare beneficiaries hospitalized withnew occurrences of
acute myocardial infarction (AMI, or heart attacks) from 1984 through
1994, as well as for all elderly beneficiaries hospitalized for ischemic
heart disease (IHD) from 1984 through 1994. To evaluate quality ofcare
from the standpoint of a person in the communityexperiencing heart
disease, we assign each patient to the hospital to which shewas first
admitted with that diagnosis. Our population includesover 200,000
AMI patients and over 350,000 IHD patientsper year. We limit our
analysis of hospital performance to U.S. general short-term hospitals
with at least two admissions in each year, a total of 3,954 hospitals that
collectively treated over 92 percent of these patients.
For each AMI and IHD patient, our mortalitymeasure is whether
the patient died (for any reason) withinseven, thirty or 365 days of
admission. Mortality information includes all out-of-hospital deaths.
Our complication measure is whether the patientwas readmitted
(at any hospital) between thirty and 365 days of admission fora car-
diac-related diagnosis. For each hospital, we construct risk-adjusted124 McClellan and Staiger
outcome rates for each year and eachdiagnosis. These estimated hospi-
tal-specific intercepts are from a patient level regression(run separately
by year, diagnosis, and outcome measure)that estimates the average
outcome rate in each hospital, controllingfor a fully interacted set of in-
dicators for age, gender, black or nonblack race,and rural location.
These estimates provide the conventional qualityindicators on which
our filtered estimates arebased.
Identifying High-Quality Hospitals
As we saw in table 5.1, conventional qualityindicators are unstable
over time and are poor predictorsof future hospital performance. In ta-
ble 5.2, we show that this is not true whenhospitals are ranked based
on our filtered quality estimates.As in table 5.1, we focus on thirty-day
AMI mortality as the outcome measure. Based onfiltered estimates (us-
ing data available from 1984-1990), weidentified the "best" and
"worst" hospitals in 1990 as those in the top and bottomdeciles in
terms of thirty-day AMI mortality. The"best" hospitals are those with
the best outcomes, those in the lowest decile offiltered mortality rates.
Table 5.2 indicates how these best (column 1)and worst (column 2)
hospitals performed two and four years later.
In contrast with conventional methods (seetable 5.1), our filtering
method can consistently identify best and worst hospitalsand forecast
future performance. Table 5.2 shows that, of the hospitalsranked in the
best 10 percent by filtered measures in 1990, 52.1 percent arestill
ranked in the best 10 percent in 1992 and 42 percent arestill in the best
10 percent in 1994. Almost none of thesehospitals show up in the worst
10 percent in 1992 and 1994. The performanceof hospitals we rank in
the worst 10 percent in 1990 is similar, with 53.8 percent(43.4 percent)
remaining in the worst 10 percent in 1992 (1994), and noneshowing up
in the best 10 percent. Obviously, the differencebetween the results for
conventional measures of thirty-day mortality (table 5.1) andthe
filtered measures (table 5.2) reflect the fact thatconventional quality in-
dicators in any given year are quite imprecise. As aresult, the correla-
tion in a hospital's ranking from one year tothe next is quite
lowbelow 0.2 between any two given years forconventional
thirty-day AMI mortality rates. In contrast, filteredestimates of
thirty-day AMI mortality rates do not change much overtime: filtered
estimates are correlated .96 between 1994 and 1992,and .89 between
1994 and 1990.Comparing the Quality of Health Care Providers 125
Table 5.2
Comparisons of hospital rankings: 1990, 1992, and 1994
Ranked in best 10% Ranked in worst 10%
(lowest mortality rate)(highest mortality rates)
in 1990 in 1990
Of the hospitals ranked as
indicated in 1990:
1992
Note: Rankings based on filtering methods. Outcome measure: Filtered risk-adjusted
thirty-day AMI mortality.
Even more important, mortality rates in 1992 and 1994 for the hospi-
tals ranked in the best and worst 10 percent in 1990are significantly
different from the remaining 80 percent of hospitals (see table5.2). Hos-
pitals ranked in the best 10 percent in 1990 had,on average, 3.8 percent-
age points lower mortality in 1992, and 3.5 percentage points lower
mortality in 1994, relative to the middle 80 percent of hospitals. Con-
versely, hospitals ranked in the worst 10 percent in 1990 had 3.7per-
centage points higher mortality in 1992, and 3.6 percentage points higher
mortality in 1994, relative to the middle 80 percent of hospitals. These
differences in mortality are large relative to theaverage thirty-day mor-
tality rate for AMI patients of about 19 percent in 1994. They implythat
Percentage ranked in best 10%
(lowest mortality rates)
52.1% 0%
Percentage ranked in worst 10%
(highest mortality rates)
0.3% 53.8%
Difference in mortality rate from
middle 80% of hospitals
- .037 + .037
(Standard error) (.004) (.005)
Predicted difference in mortality
from middle 80% of hospitals,
based on 1990 forecast
- .038 + .042
1994
Percentage ranked in best 10%
(lowest mortality rates)
42.0% 0%
Percentage ranked in worst 10%
(highest mortality rates)
0% 43.4%
Difference in mortality rate from
middle 80% of hospitals
- .035 + .036
(Standard error) (.004) (.006)
Predicted difference in mortality
from middle 80% of hospitals,
based on 1990 forecast
.029 +032126 McClellan and Staiger
the hospitals we rank in the best 10 percent using filtereddata in 1990
had a mortality rate of 15.5 percent in 1994, while thehospitals ranked
in the worst 10 percent in 1990 had a mortality rateof 22.6 percent in
1994. In fact, forecasts derived from the filteringmethodology, based
only on data available through 1990, accurately predicted thesediffer-
ences in 1992 and 1994 as seen in thefourth and eighth rows of table
5.2. Thus, hospital rankings based on the filtered estimates appearto
identify large and persistent differences across hospitals inpatient
outcomes.
Comparing Alternative Quality Indicators
Is thirty-day AMI mortality the right quality indicator tofocus on?
Would hospital rankings change if one controlled foradditional (but
costly) information on differences in patient severity andcomorbidity
across hospitals? Ideally we wouldlike to limit the number of quality
indicators being collected and reported, both to reducedata collection
costs and to simplify reporting. One method of doing sowould be to
compare hospital rankings across qualityindicators: if two quality in-
dicators produce similar rankings, then one of them (the more expen-
sive, or the one that identifies smaller differences acrosshospitals)
could be eliminated. The imprecision found in conventionalquality in-
dicators makes such a comparison difficult because it can generate a
low correlation between any two quality indicators (as we sawin com-
parisons from one year to the next). By reducing the imprecisionfound
in conventional quality indicators, filtered measures canbe used more
easily to compare alternative quality indicators, choose among poten-
tial indicators, and evaluate the bias in measures that do notfully con-
trol for differences in patient severity and comorbidity acrosshospitals.
Table 5.3 contains estimates from 1994 of the relationshipbetween
various quality indicators and thirty-day AMI mortality.The first two
columns are based on filtered measures, and the second twocolumns
are based on conventional estimates(unfiltered). For both filtered and
conventional estimates, we report the standard deviation of each qual-
ity indicator across hospitals (a measure of the variation inthe esti-
mated outcome rate across hospitals) and the correlationof each
indicator with thirty-day AMI mortality.
We consider various alternative quality indicators. First, weconsider
an alternative measure ofthirty-day AMI mortality that controls for aComparing the Quality of Health Care Providers 127
Table 5.3
Comparisons across alternative outcome measures (filtered versus conventional esti-
mates)
aComparison of thirty-day AMI mortality adjusted for patient demographics with
thirty-day AMI mortality adjusted for detailed patient risk factors is based on data from
Health Care Financing Administration's (HCFA's) cooperative cardiovascular project.
All other comparisons are based on measures derived from Medicare claims data as
described in the article.
detailed set of patient severity and comorbidity variables developed
from comprehensive chart reviews; these patient data are far more de-
tailed than the information available in claims These data, which were
developed for the hospitals in our study through HCFA's Cooperative
Cardiovascular Project, can provide evidence on whether rankings
based on claims data are biased by the lack of detailed risk adjusters.
We also compare thirty-day mortality to seven-day and one-year mor-
tality for AMI patients. The correct amount of follow-up time isun-
clear, and shorter-term mortality is generally cheaper to collect. Ina
third comparison, we consider a measure capturing a broader range of
adverse outcomes for AMI: either death or readmission for a cardiac
diagnosis within one year. We do not count readmissions in the first
thirty days as adverse events because many of these are for appropriate
follow-up care, e.g., bypass surgery. Finally, we consider a quality mdi-
















adjustmenta .029 .91 .096 .91
7-day AMI
mortality .024 .99 .079 .82
30-day AMI
mortality .028 1 .095 1
1-year AMI
mortality .031 .95 .107 .75
Mortality or
cardiac readmit
within 1 year .032 .72 .109 .56
1-year IHD
mortality .014 .62 .065 .04128 McClellan and Staiger
cator for an entirely different sample of patients: one-year mortalityfor
patients with ischemic heart disease (IHD). Like AMI, IHD is a cardiac
condition and one would expect quality of care to be positively corre-
lated across these two closely related medical conditions.
Two facts are apparent from table 5.3. First, the filtered measures
vary considerably across hospital (column 1),with a standard devia-
tion of around 3 percentage points for the AMI measures (seven-day,
thirty-day and one-year mortality and one-year mortality or readmit),
and 1.4 percentage points for one-year IHD mortality. Conventional es-
timates are considerably more variable for every quality indicator (col-
umn 3), but most of this variation is a result of the noisein conventional
estimates.
The second fact apparent from table 5.3 is that many of the filtered
measures are highly correlated. Most important, wefind that the
filtered thirty-day AMI mortality rate (which controls only for differ-
ences across hospitals in a limited set of patientdemographics) is
highly correlated (0.91) with a filtered thirty-day AMI mortality rate
based on detailed risk adjustment. In other words, filtered AMI mortal-
ity rates, based on limited risk-adjustment using only the patient vari-
ables commonly available in claims data, generate essentially the same
rankings as measures based on more detailed risk adjustment that re-
quire more extensive data collection. Thus, for this example, there ap-
pears to be little bias in hospital rankings that rely onAMI mortality
measures derived from claims data.
Filtered thirty-day AMI mortality rates are even more highly corre-
lated (over 0.95) with seven-day and one-year mortality. In other
words, filtered short-term (even seven-day) mortality rates generate es-
sentially the same rankings as long-term mortality measures that re-
quire more extensive patient follow-up. Thus, at least for AMI
admissions, there appears to be little reason to incur the extra costs and
delays involved in collecting long-term mortality information.
Finally, the correlation of filtered thirty-day mortality with the re-
maining measures (AMI mortality or cardiac readmission within one
year, one-year IHD mortality) is less strongbut still above 0.6. While
these quality indicators are related to AMI mortality, they do seem to
capture independent information on hospital quality along otherdi-
mensions. Thus, these two measures may provide useful additional in-
formation for comparing hospitals.
Our conclusions would have been quite different if we had tried to
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cators. Because these conventional estimates are based on small sam-
ples from a single year, they are imprecise. As a result, they tend to
understate considerably the correlation between thirty-day AMI mor-
tality and the alternative measures, especially when making compari-
sons to a measure from a different sample of patients (e.g., one-year
IHD mortality) because the estimation error in such measures is
uncorrelated. For other measures (e.g., thirty-day AMI mortality with
detailed risk adjustment) the conventional estimates remain highly cor-
related because the noise in the two measures is highly correlatede.g.,
a chance death for a few average patients will adversely affect both
measures.
Overall, this example illustrates how comparisons across filtered
quality measures can be used to identify a subset of core quality indica-
tors. This example provides an empirical basis on which to eliminate
redundant measures (such as long-term mortality). It also provides an
empirical basis on which to explore the potential bias in claims-based
measures.
Comparing Hospitals in a Metropolitan Market
One of the goals in developing quality indicators is to allow meaning-
ful comparisons to be made across hospitals in a given region or mar-
ket. Thus, from a practical standpoint, quality indicators must be
precise enough to allow one to identify consistently the best (and
worst) hospitals in a market. The filtered estimates for thirty-day AMI
mortality are quite precise relative to conventional quality indicators
and appear to be quite useful for comparing hospitals within markets
(for example, see McClellan and Staiger 1999b).
To illustrate this point, figure 5.1 presents plots of filtered and con-
ventional estimates of thirty-day AMI mortality rates for 1994 (relative
to the national average) for twenty-six hospitals ranging in size from
fifteen to 175 AMI admissions and located in a large metropolitan area.
In this figure, hospitals are ordered from left to right according to how
they rank among the twenty-six hospitals in terms of the filtered (bot-
tom panel) and conventional (top panel) measures. The vertical axis
gives the estimated mortality rate (relative to the national average),
with a value of 0.1, for example, indicating that mortality at the hos-
pital was ten percentage points below the national average. Confidence
bars indicate a 1.4 standard error confidence interval around each hos-
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B. Filtered 30-day AMI mortality rates
Figure 5.1
Comparison of unfiltered (panel A) and filtered (panel B) 30-day AMI mortality rates at
hospitals in a large metropolitan region, 1994
Absolute difference between each hospital's mortality rate and the national average in
1994, adjusted for patient demographics. Error bars provide a 1.4 SE confidence interval,
so that hospitals with nonoverlapping intervals are statistically different at the 5% level.
The horizontal line marks the median mortality rate in the region. Hospitals labeled "H"
and "L" were identified as high and low mortality hospitals, respectively, based on
filtered mortality rates in 1994.
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tervals are statistically different at the 5 percent level. In each panel,we
have drawn a horizontal line through the median mortality rate in the
area as a reference point.
It is apparent that the filtered estimates (bottom panel) are much
more precise than are the conventional estimates (top panel). The
confidence intervals on the filtered estimates are roughly half the size
of the intervals on the conventional estimates, with the improvement in
precision much greater for the smallest hospitals.1 The extreme esti-
mates apparent in the conventional measures (a few hospitals with a
mortality more than fifteen percentage points away from the median)
are not present in the filtered estimates. Nonetheless, the filtered esti-
mates identify large differences in mortality rates:six hospitals
(marked "L" in figure 5.1) have filtered confidence intervals lyingen-
tirely below the median, while another five hospitals (marked "H" in
figure 5.1) have filtered confidence intervals lying entirely above the
median. The difference in average estimated mortality rates between
hospitals in these low and high mortality groups is over eight percent-
age points.
Another way to demonstrate the ability of the filtered estimates to
identify differences consistently across hospitals is to plot themeasures
over time. Figure 5.2 plots conventional estimates of thirty-day AMI
mortality rates for each hospital in the region between 1984 and 1994.
To reduce clutter, we have broken the sample into four roughly equal
groups based on the average annual number of AMI admissions at
each hospital over this time period, and we plot the data for each group
separately. For comparison, we continue to label those hospitals
identified by the filtered measures as having high (H) and low (L)mor-
tality in 1994.
The imprecision in conventional estimates is immediately apparent
from figure 5.2. The conventional mortality estimates change dramati-
cally from year to year and follow no apparent pattern. As a result, it is
nearly impossible to identify hospitals that have consistently low or
high mortality, and equally impossible to discern any trends in these
measures over time.
In contrast, the same plot using filtered data (figure 5.3) can identify
clearly the differences across hospitals and over time. Hospitals that
were ranked as having high (H) mortality in 1994 have consistently
had high mortality over this period, although some showed more im-
provement over time than others. Similarly, hospitals that were ranked

















Comparison of unfiltered 30-day AlvIl mortality rates at hospitals in a large metropolitan
region, 1984-1994
Plotted separately by average annual Alvil volume: 16-44 admissions per year (upper
left), 44-80 admissions per year (upper right), 80-115 admissions per year (lower left),
and 115-175 admissions per year (lower right). The vertical axis gives the absolute differ-
ence between each hospital's mortality rate and the national average inthat year, ad-
justed for patient demographics. Hospitals labeled "H" and "L" were identified as high
and low mortality hospitals, respectively, based on filtered mortality rates in 1994.
have low mortality throughout the period. Among the largest hospitals
(115 to 175 AMI admissions), the filtered estimates can identify changes
in the relative rankings among the three best hospitals in the region.
Thus, this example suggests that the filtered measures can be used to
make meaningful comparisons across hospitals and over time within a
large metropolitan region.
V.Implications
This article provides a brief overview of how our method for extracting
the signal from many noisy quality measures can support better evalu-
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Figure 5.3
Comparison of filtered 30-day AMI mortality rates at hospitals in a large metropolitan re-
gion, 1984-1994
Plotted separately by average annual AMI volume: 16-44 admissions per year (upper
left), 44-80 admissions per year (upper right), 80-115 admissions per year (lower left),
and 115-1 75 admissions per year (lower right). The vertical axis gives the absolute differ-
ence between each hospital's mortality rate and the national average in that year, ad-
justed for patient demographics. Hospitals labeled "H" and "L" were identified as high
and low mortality hospitals, respectively, based on filtered mortality rates in 1994.
sented here illustrate how the method may offer an integrated solution
to the key problems that limit the usefulness of currently available
quality indicators. Compared to existing methods for assessing the
quality of health care providers, our approach has several advantages.
It limits measurement costs by providing a sound empirical basis for
comparing and choosing among alternative quality indicators. More
important, our method performs far better than alternative approaches
for eliminating the noise problem that has plagued efforts to develop
and apply practical quality indicators.
We are applying these methods to a larger range of health problems,
patient populations, and provider networks and integrating them into
quality improvement programs. These efforts require collaboration134 McClellan and Staiger
among analysts, health plans, providers, purchasing groups, and gov-
ernment agencies to collect and integrate relevant information for con-
structing the quality measures and using them to help guide decision
making and improve provider quality.
One feature of our collaborative work is the use of meaningful qual-
ity measures that would be difficult or impossible for individual partic-
ipants in the collaboration to obtain. For example, the most important
performance measures for serious health conditions like heart disease
and cancer involve long-term outcomes (e.g., two-year mortality),
which are costly or impossible for providers and health insurers to col-
lect. In contrast, government agencies commonly collect mortality and
disease surveillance data needed for constructing such measures, but
they may not have information on the responsible medical groups or
physicians for the patients involved. Through the participation of all of
these groups, constructing measures of quality for serious health con-
ditions becomes feasible.
Another feature of our approach is the optimization of the use of de-
tailed but costly clinical data to account for patient characteristics that
may result in biased measures of quality. As weillustrated here, we in-
clude some measures based on clinically detailed risk adjustment (e.g.,
with data drawn from chart abstracts) for some of the patients in our
analysis to evaluate potentially important differences across providers
in patient severity of illness. Using these gold standard measures, we
can identify valid proxy measures that are less costly and morereadily
available or adjust these measures appropriately. As a result, we can
extract more reliable data about true provider quality from the lower
cost measures. These steps minimize the overall resource burden of our
data collection and measure development and improve their validity.
A third component of our collaboration involves integrating our new
outcome-based measures with those developed in established continu-
ous quality improvement initiatives, for example, thestandardized
measures of patient satisfaction and process of care developedby the
National Committee for Quality Assurance (NCQA). These measures
have been tested and applied extensively, but their relationship with
important outcomes of care is not well understood. We are investigat-
ing the relationship between performance in these dimensions of qual-
ity and important outcomes of care to determine the extent to which
these readily available measures can substitute for more comprehen-
sive outcome evaluations.
The most important goal for many of our collaborators is to use these
measures to improve quality of care. First, we are identifying the struc-Comparing the Quality of Health Care Providers 135
tural features and processes of care that are related most closely to im-
portant outcomes and thus identifying specific practice changes that
are most likely to improve provider quality Our methods provide em-
pirical evidence of the magnitude and direction of relationships be-
tween these modifiable factors and outcomes. Such evidence can be
used to ensure that continuous quality initiatives focus on identifying
and changing provider practices where there is the greatest opportu-
nity for improving outcomes. Second, our methods can be used to ob-
tain much more precise estimates of the impact of interventions suchas
provider training or patient education.
Through all of these steps, our collaborative approach to quality
evaluation and improvement is developing performance measures that
are precise and reliable and therefore more acceptable to providers and
payers. This undertaking is complex and long term, but our results to
date suggest that the potential for evidence-based quality improve-
ment in health care is much greater than many experts now believe.
Notes
Prepared for the NBER conference on Frontiers in Health Policy Research, June 17, 1999,
Washington DC. This article draws heavily on our own ongoing work and work with
various collaborators. The National Institute of Aging, The Health Care Financing Ad-
ministration, and the Olin Foundation provided financial support at various times for
this work. We thank Jon Skinner and Jeff Geppert for helpful comments on an earlier
draft. We also thank our collaborators, including Jeffrey Geppert, Jeffrey Horbar, Thomas
Kane, Haruko Noguchi, Jeannette Rogowski, and Yu-Chu Shen.
1. Note that one cannot make direct comparison across the two panels because hospitals
are ranked differently by the two measures.
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